Association of cognitive frailty and its changes with cardiovascular–kidney–metabolic multimorbidity: Findings from the CHARLS study
Ageing Research Reviews · 2027-01 · 123 · 103433
DOI: 10.1016/j.arr.2026.103433 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2027-01. Verfasst von Liren Duan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, The First Hospital of China Medical University, Key Laboratory of Pathogenesis, Prevention and Therapeutics of Aortic…. Die Arbeit nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Liaoning Provincial Natural Science Foundation.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
BACKGROUND: Physical frailty has been linked to cardiovascular-kidney-metabolic (CKM) multimorbidity, but the role of cognitive frailty and its dynamic changes in CKM progression remains unclear. We investigated the associations of baseline cognitive frailty and changes in cognitive frailty status with incident CKM multimorbidity. METHODS: This cohort study included participants aged ≥ 45 years from the CHARLS (2011-2018). Cognitive frailty was classified as Robust, reversible cognitive frailty (RCF), or potentially reversible cognitive frailty (PRCF). A five-level score quantified the magnitude of cognitive change (Δscore). CKM multimorbidity was defined as ≥ 2 of cardiovascular disease, chronic kidney disease, and metabolic disease. Cox models and trend tests estimated hazard ratios (HRs) and 95% CIs. RESULTS: Among 9816 participants, 3836 were included in baseline CKM analysis and 1891 in transition analysis. Both RCF (HR=2.74, 95%CI:2.25-3.34) and PRCF (HR=2.51, 95%CI:1.96-3.21) were associated with increased CKM risk (both P < 0.001). Cognitive status provided additional risk stratification beyond physical frailty. RCF-to-Robust improvement reduced CKM risk by 56% (HR=0.44, 95%CI:0.23-0.85, P = 0.015), while deterioration markedly increased risk (HR≈5.3, P < 0.001). The Δscore trend test showed a significant dose-response relationship (P < 0.001). Substantial improvement (Δscore=-3) significantly reduced risk, whereas minor improvements showed protective trends without statistical significance. CONCLUSIONS: Cognitive frailty is independently associated with CKM multimorbidity progression. Within each direction of cognitive change, the magnitude of change provided additional prognostic information beyond direction alone. These findings support the brain-CKM interconnection framework and suggest cognitive screening should be considered in CKM prevention strategies. LAY SUMMARY: Cognitive frailty-a condition where physical decline and memory problems occur together-is common in older adults. In this study, we analysed data from nearly 10,000 middle-aged and older adults in China to understand whether cognitive frailty increases the risk of developing cardiovascular-kidney-metabolic (CKM) multimorbidity, a cluster of conditions including heart disease, kidney disease, and diabetes. We found that people with cognitive frailty had significantly higher risks of developing CKM multimorbidity. More importantly, we found that the magnitude of change in cognitive function added prognostic information on top of its direction-greater worsening tracked with higher CKM risk. These findings suggest that monitoring changes in cognitive function over time could help identify individuals at high risk of CKM multimorbidity, and that interventions aimed at improving cognitive health may need to achieve meaningful improvement to reduce this risk.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Vascular Surgery, The First Hospital of China Medical University, Key Laboratory of Pathogenesis, Prevention and Therapeutics of Aortic Aneurysm, Shenyang, Liaoning, China.
- Department of Anesthesiology, People's Hospital of China Medical University (People's Hospital of Liaoning Province), Shenyang, China.
- Department of Surgery, Highland Community Hospital, Picayune, MS, USA.
- Department of Pharmacology, School of Pharmacy, Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, Shenyang, China.
- Center for Quality, Effectiveness, and Outcomes in Cardiovascular Diseases, Houston, TX, USA; Department of Vascular and Endovascular Surgery 2, Ascension Health, Waco, TX USA. Electronic address: mark.davies@ascension.…
- Department of Vascular Surgery, The First Hospital of China Medical University, Key Laboratory of Pathogenesis, Prevention and Therapeutics of Aortic Aneurysm, Shenyang, Liaoning, China. Electronic address: jianzhang@cm…
Förderung
- National Natural Science Foundation of China
- Liaoning Provincial Natural Science Foundation
Zitieren
APA
Duan, L., Li, S., Yan, Q., Lun, Y., Wang, S., He, Y., Yang, Y., Zhao, L., Davies, M. G., & Zhang, J. (2027). Association of cognitive frailty and its changes with cardiovascular–kidney–metabolic multimorbidity: Findings from the CHARLS study. Ageing Research Reviews, 123, 103433. https://doi.org/10.1016/j.arr.2026.103433
Vancouver
Duan L, Li S, Yan Q, Lun Y, Wang S, He Y, et al. Association of cognitive frailty and its changes with cardiovascular–kidney–metabolic multimorbidity: Findings from the CHARLS study. Ageing Research Reviews. 2027;123:103433. doi:10.1016/j.arr.2026.103433
BibTeX
@article{Duan2027,
author = {Duan, Liren and Li, Shenli and Yan, Qi and Lun, Yu and Wang, Shiyue and He, Yuchen and Yang, Yu and Zhao, Lin and Davies, Mark G and Zhang, Jian},
title = {Association of cognitive frailty and its changes with cardiovascular–kidney–metabolic multimorbidity: Findings from the CHARLS study},
journal = {Ageing Research Reviews},
year = {2027},
volume = {123},
pages = {103433},
doi = {10.1016/j.arr.2026.103433}
}
EUVIMED